All News
Filter News
Found 808,277 articles
-
Aetion Closes $110M Series C Funding Round Led by Warburg Pincus
5/11/2021
Financing will advance Aetion's technology, accelerate global growth, and drive expansion in new verticals, further cementing Aetion's leadership position in real-world evidence
-
Capital Rx and 3 Axis Advisors Study Finds Potential for Billions in Prescription Drug Savings With Transparent Pricing Practices
5/11/2021
Mandatory NADAC responses by pharmacies for 1,600 unique oral solid products could create additional savings of $1.5 billion over 10 years
-
Neurocrine Biosciences to Present at the 2021 RBC Global Healthcare Conference
5/11/2021
Neurocrine Biosciences, Inc. will present at the 2021 RBC Capital Markets Healthcare Conference at 10:55 a.m. Eastern Time on Tuesday May 18, 2021.
-
Precision Optics Corporation Schedules Third Quarter Fiscal Year 2021 Conference Call for Thursday, May 13, 2021
5/11/2021
Precision Optics Corporation, Inc. announced that it has scheduled a conference call to discuss third quarter fiscal year 2021 financial results on Thursday, May 13, 2021 at 5:00pm ET.
-
CymaBay Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 11, 2021
5/11/2021
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, announced the grant of an inducement award to Lewis Stuart in connection with his appointment as the company’s Chief Commercial Officer.
-
Harmony Biosciences Reports First Quarter 2021 Results and Business Updates
5/11/2021
Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, reported financial results and business updates for the first quarter ended March 31, 2021.
-
Akorn announces two key executive appointments - May 11, 2021
5/11/2021
Akorn Operating Company LLC, a leading specialty pharmaceutical company, announced two new executive appointments.
-
Magnolia Medical Joins Emergency Nurses Association's Corporate Engagement Council as Category-Exclusive Member
5/11/2021
Partnership formed to create greater awareness of patient safety risks of false-positive diagnostic test results for sepsis and new technologies that address blood culture contamination
-
Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update
5/11/2021
OP-1250 continues to advance in dose-escalation stage of Phase 1/2 clinical trial in patients with metastatic, ER+ / HER2- breast cancer; Initial data anticipated in 2H 2021
-
Allena Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
5/11/2021
Enrollment ongoing in Phase 3 URIROX-2 clinical trial of reloxaliase; interim analysis expected 2Q or 3Q 2022
-
Delcath Systems, Inc. Announces First Quarter 2021 Results
5/11/2021
Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported business highlights and financial results for the first quarter ended March 31, 2021.
-
Praxis Precision Medicines Announces Proposed Public Offering of Common Stock - May 11, 2021
5/11/2021
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, announced that it has commenced an underwritten public offering of 4,000,000 shares of its common stock.
-
SANUWAVE Health Announces Issuance of Eleven New Patents Bringing the Company's Total Number of Active Patents and Patent Applications to 150
5/11/2021
Patents and patent applications provide additional coverage for the company's shockwave and ultrasound technologies in medical and non-medical fields
-
Seegene's Germany subsidiary supports the back-to-school initiative with its COVID-19 tests
5/11/2021
Seegene Inc., a leading molecular diagnostics firm said its German subsidiary, Seegene Germany GmbH is taking part in the government's Back-to-School program called the "Lolli-Test," a starting point in returning our daily lives back to normalcy.
-
OracleBio Launch GCP Image Analysis Services
5/11/2021
OracleBio announced the launch of the company’s GCP Image Analysis Services.
-
First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model
5/11/2021
Preclinical data validate that human T-cells expressing a TCR targeting mesothelin, independent of HLA recognition, can kill human tumor cells
-
The ALS Association Massachusetts Chapter Hosts Inaugural “CEO Soak” on June 10 in Downtown BostonEvent Builds on Ice Bucket Challenge Legacy to Raise Funds for Local Families Living with ALS
5/11/2021
The ALS Association Massachusetts Chapter is encouraging local leadership to get soaked for a great cause.
-
Iridex Announces First Quarter 2021 Financial Results
5/11/2021
We enjoyed a strong start to 2021 and our positive momentum continued with revenue that exceeded pre-COVID levels, setting a record for first quarter revenue.
-
Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update
5/11/2021
Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, reported financial results for the quarter ended March 31, 2021 and provided an update on its product pipeline and corporate activities.
-
aTyr Pharma Announces Promotion of Leslie Nangle, Ph.D., to Vice President of Research
5/11/2021
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced the promotion of Leslie Nangle, Ph.D., to Vice President, Research.